FDA warnings and reports of ‘internal bra’ complications may lead to a surge in breast mesh lawsuits

Breast mesh implants promoted as “internal bra” supports have become the subject of legal and regulatory scrutiny. Not cleared for this use by the FDA, the mesh implants have been linked to higher rates of infections, reoperation and implant failure.

The “internal bra” technique uses synthetic or biologic mesh in combination with other breast surgeries to lift breasts and enhance results. In November 2023, the FDA released a safety communication emphasizing that no surgical mesh products are cleared or approved for use in breast surgeries. Despite this, mesh products have seen increased off-label use for internal bra techniques in breast surgeries with implants.

There are approximately 100,000 breast reconstruction surgeries per year and more than 300,000 breast augmentation surgeries per year in the US. The use of breast mesh in these procedures could put people at risk of higher complication rates.

Read full article.

Source: Drugwatch, 30 October 2025